This notion is further supported by the fact that both NS and LS are associated with increased risk of hematologic malignancies although PTPN11 mutations found in NS and LS activate and inactivate SHP-2 enzymatic activity, respectively. Here, PTPN11 is linked to Leigh syndrome.